- Home
- HERE vs FENC Comparison
HERE vs FENC Comparison
Compare HERE & FENC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
Current Price
$5.42
HOLD
Current Price
$7.86
Company Overview
Basic Information| Metric | HERE | FENC |
|---|---|---|
| Founded | 2019 | 1996 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 296.4M | 276.3M |
| IPO Year | 2023 | 2001 |
Fundamental Metrics
Financial Performance| Metric | HERE | FENC |
|---|---|---|
| Price | $5.42 | $7.86 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $13.50 |
| AVG Volume (30 Days) | ★ 259.6K | 184.5K |
| Earning Date | 12-02-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 43.17 | N/A |
| EPS | ★ 1.45 | N/A |
| Revenue | ★ $286,877,037.00 | $38,790,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $70.97 |
| P/E Ratio | $8.40 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.60 | $4.68 |
| 52 Week High | $15.64 | $9.92 |
Technical Indicators
Market Signals| Indicator | HERE | FENC |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 52.61 |
| Support Level | N/A | $7.43 |
| Resistance Level | N/A | $7.83 |
| Average True Range (ATR) | 0.00 | 0.28 |
| MACD | 0.00 | 0.05 |
| Stochastic Oscillator | 0.00 | 81.06 |
Price Performance
Historical Comparison HERE
FENC
About FENC Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.